These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 22373082

  • 1. Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo.
    Lahlou H, Sanguin-Gendreau V, Frame MC, Muller WJ.
    Breast Cancer Res; 2012 Feb 28; 14(1):R36. PubMed ID: 22373082
    [Abstract] [Full Text] [Related]

  • 2. Protein tyrosine kinase 6 promotes ERBB2-induced mammary gland tumorigenesis in the mouse.
    Peng M, Ball-Kell SM, Tyner AL.
    Cell Death Dis; 2015 Aug 06; 6(8):e1848. PubMed ID: 26247733
    [Abstract] [Full Text] [Related]

  • 3. Mammary gland-specific ablation of focal adhesion kinase reduces the incidence of p53-mediated mammary tumour formation.
    van Miltenburg MH, van Nimwegen MJ, Tijdens I, Lalai R, Kuiper R, Klarenbeek S, Schouten PC, de Vries A, Jonkers J, van de Water B.
    Br J Cancer; 2014 May 27; 110(11):2747-55. PubMed ID: 24809783
    [Abstract] [Full Text] [Related]

  • 4. Mammary epithelial-specific disruption of focal adhesion kinase retards tumor formation and metastasis in a transgenic mouse model of human breast cancer.
    Provenzano PP, Inman DR, Eliceiri KW, Beggs HE, Keely PJ.
    Am J Pathol; 2008 Nov 27; 173(5):1551-65. PubMed ID: 18845837
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in mammary tumour progression.
    Rao T, Ranger JJ, Smith HW, Lam SH, Chodosh L, Muller WJ.
    Breast Cancer Res; 2014 Jan 23; 16(1):R11. PubMed ID: 24457046
    [Abstract] [Full Text] [Related]

  • 7. Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression.
    Lahlou H, Sanguin-Gendreau V, Zuo D, Cardiff RD, McLean GW, Frame MC, Muller WJ.
    Proc Natl Acad Sci U S A; 2007 Dec 18; 104(51):20302-7. PubMed ID: 18056629
    [Abstract] [Full Text] [Related]

  • 8. Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells.
    Luo M, Fan H, Nagy T, Wei H, Wang C, Liu S, Wicha MS, Guan JL.
    Cancer Res; 2009 Jan 15; 69(2):466-74. PubMed ID: 19147559
    [Abstract] [Full Text] [Related]

  • 9. Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis.
    Deng X, Li Q, Hoff J, Novak M, Yang H, Jin H, Erfani SF, Sharma C, Zhou P, Rabinovitz I, Sonnenberg A, Yi Y, Zhou P, Stipp CS, Kaetzel DM, Hemler ME, Yang XH.
    Neoplasia; 2012 Aug 15; 14(8):678-89. PubMed ID: 22952421
    [Abstract] [Full Text] [Related]

  • 10. Function of focal adhesion kinase scaffolding to mediate endophilin A2 phosphorylation promotes epithelial-mesenchymal transition and mammary cancer stem cell activities in vivo.
    Fan H, Zhao X, Sun S, Luo M, Guan JL.
    J Biol Chem; 2013 Feb 01; 288(5):3322-33. PubMed ID: 23255596
    [Abstract] [Full Text] [Related]

  • 11. The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.
    Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J.
    J Clin Invest; 2008 Jan 01; 118(1):64-78. PubMed ID: 18079969
    [Abstract] [Full Text] [Related]

  • 12. beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression.
    Huck L, Pontier SM, Zuo DM, Muller WJ.
    Proc Natl Acad Sci U S A; 2010 Aug 31; 107(35):15559-64. PubMed ID: 20713705
    [Abstract] [Full Text] [Related]

  • 13. FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors.
    Paul R, Luo M, Mo X, Lu J, Yeo SK, Guan JL.
    Breast Cancer Res; 2020 Jun 03; 22(1):59. PubMed ID: 32493400
    [Abstract] [Full Text] [Related]

  • 14. Compensatory function of Pyk2 protein in the promotion of focal adhesion kinase (FAK)-null mammary cancer stem cell tumorigenicity and metastatic activity.
    Fan H, Guan JL.
    J Biol Chem; 2011 May 27; 286(21):18573-82. PubMed ID: 21471206
    [Abstract] [Full Text] [Related]

  • 15. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
    Wellberg EA, Johnson S, Finlay-Schultz J, Lewis AS, Terrell KL, Sartorius CA, Abel ED, Muller WJ, Anderson SM.
    Breast Cancer Res; 2016 Dec 20; 18(1):131. PubMed ID: 27998284
    [Abstract] [Full Text] [Related]

  • 16. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
    Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418
    [Abstract] [Full Text] [Related]

  • 17. Rab11-FIP1C Is a Critical Negative Regulator in ErbB2-Mediated Mammary Tumor Progression.
    Boulay PL, Mitchell L, Turpin J, Huot-Marchand JÉ, Lavoie C, Sanguin-Gendreau V, Jones L, Mitra S, Livingstone JM, Campbell S, Hallett M, Mills GB, Park M, Chodosh L, Strathdee D, Norman JC, Muller WJ.
    Cancer Res; 2016 May 01; 76(9):2662-74. PubMed ID: 26933086
    [Abstract] [Full Text] [Related]

  • 18. USP22 overexpression fails to augment tumor formation in MMTV-ERBB2 mice but loss of function impacts MMTV promoter activity.
    Kuang X, Salinger A, Benavides F, Muller WJ, Dent SYR, Koutelou E.
    PLoS One; 2024 May 01; 19(1):e0290837. PubMed ID: 38236941
    [Abstract] [Full Text] [Related]

  • 19. Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation.
    van Nimwegen MJ, Verkoeijen S, van Buren L, Burg D, van de Water B.
    Cancer Res; 2005 Jun 01; 65(11):4698-706. PubMed ID: 15930288
    [Abstract] [Full Text] [Related]

  • 20. Complete focal adhesion kinase deficiency in the mammary gland causes ductal dilation and aberrant branching morphogenesis through defects in Rho kinase-dependent cell contractility.
    van Miltenburg MH, Lalai R, de Bont H, van Waaij E, Beggs H, Danen EH, van de Water B.
    FASEB J; 2009 Oct 01; 23(10):3482-93. PubMed ID: 19584305
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.